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Adam J. Gadzinski, B.S., William W. Roberts, M.D., Gary J. Faerber, M.D., and J. Stuart Wolf, Jr., M.D.
We thank Drs. Mandal and Goel for their interest inour work, but we disagree with their interpretation of
the literature compared with our findings. While Waldert
and associates1 did indeed find a correlation between a longer
delay to nephroureterectomy (NUx) and more advanced
stage, they did not report metastasis-free survival. Moreover,
they found no difference in cancer-specific survival. Thus,
given that we also observed a progression of local disease in
some patients but found no survival differences, we hold that
our results are not contradictory to the findings of Waldert
and associates. In addition, we limited delayed patients to
those pursuing endoscopic management vs the heterogeneous
reasons for delay found in their study.
We agree that elective endoscopic management is not ap-
propriate for patients who present with muscle-invasive or
high-grade disease. As we reported previously, however,
endoscopic management may be considered an alternative in
such patients who also have absolute indications to pursue
nephron-sparing management.2 For patients with small low-
grade tumors, elective endoscopic management should be
considered as a legitimate option if experienced personnel
and the necessary equipment are available. As endoscopic
technology and surgical capabilities continue to disseminate
around the globe, more patients may be offered this option.
We do acknowledge that endoscopic procedures are not
free of complications and that there are risks associated with
repeated anesthetic administrations in elderly patients. As we
discussed, however, there is a substantial 90-day mortality
risk associated with NUx in elderly populations, reaching
8.3% in patients > 80 years old.3 Given that the most common
cause of death was renal insufficiency, we hold that ureteral
strictures and other endoscopic complications (which in fact
are uncommon) are acceptable risks for elderly patients with
small low-grade upper tract urothelial carcinoma.
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